Related Experiment Video
Updated: Dec 18, 2025

Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
Choosing a Mobile Sensor Technology for a Clinical Trial: Statistical Considerations, Developments and Learnings
Colleen Russell1, Marie McCarthy2, Joseph C Cappelleri3
1RussStat Consulting, LLC, 102 E Broadway Street #496, Prosper, TX, 75078, USA. RussStatConsulting@gmail.com.
Abstract:
The DIA Study Endpoints Community Working Group on Mobile Sensor Technology (MST) series addresses considerations that may be useful for selecting MST for use in a clinical trial. This article describes considerations regarding the selection of MST for clinical trials including expectations around technology specifications, verification (bench testing), regulatory clearance and certification status. We identify useful statistical methods needed to establish agreement of the MST with respect to a clinical 'gold' standard technology in terms of accuracy and precision, and to combine data across trials, data types or device versions. In addition to describing key considerations, this manuscript also serves as a central location citing those resources where additional detail can be found.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

